within Pharmacolibrary.Drugs.ATC.D;

model D10AX06
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.01,
    Cl             = 18 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,
    adminCount     = 1,
    Vd             = 0.05,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Clascoterone is a topical androgen receptor antagonist used primarily in the treatment of acne vulgaris. It is approved for clinical use and is marketed as a 1% cream applied to the skin. Clascoterone acts locally to block androgen receptors, thereby reducing inflammatory and noninflammatory acne lesions.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters were estimated for healthy adult subjects after topical application of clascoterone 1% cream. The data reflects systemic absorption from topical administration in humans.</p><h4>References</h4><ol><li><p>Dhillon, S (2020). Clascoterone: First Approval. <i>Drugs</i> 80(16) 1745–1750. DOI:<a href=&quot;https://doi.org/10.1007/s40265-020-01417-6&quot;>10.1007/s40265-020-01417-6</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33030710/&quot;>https://pubmed.ncbi.nlm.nih.gov/33030710</a></p></li><li><p>Manjaly, C, et al., &amp; Mostaghimi, A (2023). Clascoterone for treatment of acne. <i>Drugs of today (Barcelona, Spain : 1998)</i> 59(2) 71–81. DOI:<a href=&quot;https://doi.org/10.1358/dot.2023.59.2.3507749&quot;>10.1358/dot.2023.59.2.3507749</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36811407/&quot;>https://pubmed.ncbi.nlm.nih.gov/36811407</a></p></li><li><p>Yang, Y, et al., &amp; Xu, X (2024). Evaluation of in vitro Skin Permeation of Clascoterone From Clascoterone Topical Cream, 1% (w/w). <i>AAPS PharmSciTech</i> 25(6) 186–None. DOI:<a href=&quot;https://doi.org/10.1208/s12249-024-02887-7&quot;>10.1208/s12249-024-02887-7</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/39138712/&quot;>https://pubmed.ncbi.nlm.nih.gov/39138712</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end D10AX06;
